FOR vs SRPT · P/E 8.7, rev $1.66B vs rev $1.90B
Forestar Group Inc (FOR) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Forestar Group Inc (FOR) is a real estate - development company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported FOR revenue for 2025-09-30 was $1.66B. Net income was $167.9M. Revenue was up 10.1% from 2024-09-30 to 2025-09-30. FOR currently screens at market cap $1.45B and trailing P/E 8.7.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
FOR currently screens at market cap $1.45B and trailing P/E 8.7. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the FOR and SRPT stock pages for the full models.
Not investment advice.